| Brandi M Potter-hare, FNP-C | |
|
360 N Irby St, Florence, SC 29501-2808 | |
| (843) 667-9414 | |
| (843) 667-1362 |
| Full Name | Brandi M Potter-hare |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 360 N Irby St, Florence, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144737990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 21519 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mcleod Regional Medical Center-pee Dee | Florence, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hopehealth, Inc. | 4082510623 | 74 |
News Archive
Current research suggests that a new technique to determine tumor methylation status can be used in archived tissue samples.
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
The Dove Medical Press journal, Nature and Science of Sleep, has published a study that highlights the potential use of blood biomarkers as a diagnostic tool for obstructive sleep apnea.
The Alzheimer's Foundation of America (AFA) announced today that it has received the highest rating - four stars - from Charity Navigator, the nation's largest independent evaluator of charitable organizations.
› Verified 4 days ago
| Entity Name | Hopehealth, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821002411 PECOS PAC ID: 4082510623 Enrollment ID: O20031212000253 |
News Archive
Current research suggests that a new technique to determine tumor methylation status can be used in archived tissue samples.
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
The Dove Medical Press journal, Nature and Science of Sleep, has published a study that highlights the potential use of blood biomarkers as a diagnostic tool for obstructive sleep apnea.
The Alzheimer's Foundation of America (AFA) announced today that it has received the highest rating - four stars - from Charity Navigator, the nation's largest independent evaluator of charitable organizations.
› Verified 4 days ago
| Entity Name | Lowcountry Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326364100 PECOS PAC ID: 9739210337 Enrollment ID: O20100625000517 |
News Archive
Current research suggests that a new technique to determine tumor methylation status can be used in archived tissue samples.
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
The Dove Medical Press journal, Nature and Science of Sleep, has published a study that highlights the potential use of blood biomarkers as a diagnostic tool for obstructive sleep apnea.
The Alzheimer's Foundation of America (AFA) announced today that it has received the highest rating - four stars - from Charity Navigator, the nation's largest independent evaluator of charitable organizations.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandi M Potter-hare, FNP-C 360 N Irby St, Florence, SC 29501-2808 Ph: (843) 667-9414 | Brandi M Potter-hare, FNP-C 360 N Irby St, Florence, SC 29501-2808 Ph: (843) 667-9414 |
News Archive
Current research suggests that a new technique to determine tumor methylation status can be used in archived tissue samples.
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
The Dove Medical Press journal, Nature and Science of Sleep, has published a study that highlights the potential use of blood biomarkers as a diagnostic tool for obstructive sleep apnea.
The Alzheimer's Foundation of America (AFA) announced today that it has received the highest rating - four stars - from Charity Navigator, the nation's largest independent evaluator of charitable organizations.
› Verified 4 days ago
Mrs. Callie Hanson Carpenter, F.N.P Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2000 | |
Jessica Ann Reviea, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1594 Freedom Blvd Ste 100, Florence, SC 29505 Phone: 843-674-4787 | |
Jennifer Lucas Reid, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 214 W Pine St, Florence, SC 29501 Phone: 843-661-0500 Fax: 436-617-3708 | |
Christy Mcwhite, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 145 E Cheves St, Florence, SC 29506 Phone: 843-661-4835 | |
Betty Gattison, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1100 E Cheves St, Florence, SC 29506 Phone: 843-669-6694 | |
Theressa L Garris, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 204 E Cheves St, Florence, SC 29506 Phone: 843-777-7601 Fax: 843-662-2474 | |
Michelle D Poston, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 360 N Irby St, Florence, SC 29501 Phone: 843-667-9414 Fax: 843-667-1362 |